Relationship of Preexisting Dengue Virus (DV) Neutralizing Antibody Levels to Viremia and Severity of Disease in a Prospective Cohort Study of DV Infection in Thailand
The Journal of Infectious Diseases2004Vol. 189(6), pp. 990–1000
Citations Over TimeTop 1% of 2004 papers
Timothy P. Endy, Ananda Nisalak, Supamit Chunsuttitwat, David W. Vaughn, Sharone Green, Francis A. Ennis, Alan L. Rothman, Daniel H. Libraty
Abstract
Cross-reactive memory humoral immune responses appear to be beneficial in symptomatic secondary D3V infection, but not in secondary D2V or D1V infection. These results may have important implications for the development of live attenuated tetravalent dengue vaccines.
Related Papers
- → Dengue virus: molecular basis of cell entry and pathogenesis, 25–27 June 2003, Vienna, Austria(2004)81 cited
- → Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine(2021)14 cited
- → Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine(2014)35 cited
- → Viremia and the Magnitude of the Immune Response upon Infection of Green Monkeys with Dengue Virus Type 2 Are Strain-Dependent(2009)12 cited
- → Cellular and Molecular Basis of Antibody-Dependent Enhancement in Human Dengue Pathogenesis(2008)5 cited